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Distinct Differences on Neointima 
Formation in Immunodeficient and 
Humanized Mice after Carotid or 
Femoral Arterial Injury
Jill Moser1,†, Joris van Ark1, Marcory C. van Dijk2, Dale L. Greiner3, Leonard D. Shultz4, 
Harry van Goor1 & Jan-Luuk Hillebrands1
Percutaneous coronary intervention is widely adopted to treat patients with coronary artery disease. 
However, restenosis remains an unsolved clinical problem after vascular interventions. The role of the 
systemic and local immune response in the development of restenosis is not fully understood. Hence, 
the aim of the current study was to investigate the role of the human immune system on subsequent 
neointima formation elicited by vascular injury in a humanized mouse model. Immunodeficient NOD.
Cg-PrkdcscidIL2rgtm1Wjl (NSG) mice were reconstituted with human (h)PBMCs immediately after both 
carotid wire and femoral cuff injury were induced in order to identify how differences in the severity of 
injury influenced endothelial regeneration, neointima formation, and homing of human inflammatory 
and progenitor cells. In contrast to non-reconstituted mice, hPBMC reconstitution reduced neointima 
formation after femoral cuff injury whereas hPBMCs promoted neointima formation after carotid wire 
injury 4 weeks after induction of injury. Neointimal endothelium and smooth muscle cells in the injured 
arteries were of mouse origin. Our results indicate that the immune system may differentially respond 
to arterial injury depending on the severity of injury, which may also be influenced by the intrinsic 
properties of the arteries themselves, resulting in either minimal or aggravated neointima formation.
Percutaneous coronary interventions (PCIs) are widely used to treat patients with severe coronary atherosclerotic 
disease. Although PCI is considered an effective and safe treatment modality to establish coronary revasculari-
zation, an important drawback is the development of restenosis of the treated artery1. Restenosis is characterized 
by re-narrowing of the artery due to the formation of an occlusive neointima. Neointimal lesions are character-
ized by smooth muscle cell (SMC) proliferation and extracellular matrix deposition2. Although the causative 
mechanisms underlying development of restenosis are not fully understood, systemic and local inflammation are 
considered important driving forces1–3. Both clinical and experimental data suggest that T cell recruitment into 
the treated arterial wall promotes neointima formation, however, contradictory results have also been reported. 
Immunodeficiency in experimental models was found to augment neointima formation after arterial injury 
in both immunodeficient mice and T cell-depleted or athymic rats4–7. In contrast, adoptive T cell transfer into 
immunodeficient Rag1null mice reduced neointima formation; an effect which may be attributed to IFNγ 8. More 
recent experimental evidence identified a role for CD8+ T cells in inhibiting neointima formation7. However, in 
contrast to the protective role of T cells and IFNγ on neointima formation, transfer of CD4+ T cells increased 
atherosclerosis in ApoE/immune deficient mice9, and IFNγ was shown to augment native atherosclerosis10 and 
graft atherosclerosis11. In addition to the role of T cells in the development of restenosis, the origin of SMCs 
within neointimal lesions is also under debate. Although it was generally believed that neointimal SMCs are 
derived from the adjacent tunica media similar to SMCs in atherosclerotic lesions12, in the last 15 years it has 
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become evident that alpha-smooth muscle actin (α SMA) expressing neointimal cells derived from circulating 
progenitors can also contribute to vascular remodeling13,14. We previously demonstrated host-origin of neoin-
timal SMCs in experimental transplant vasculopathy in rats15 and more recently in human renal allografts16. 
Direct evidence supporting the contribution of (bone marrow-derived) circulating α SMA expressing cells in the 
development of human restenosis is lacking. However, human atherosclerotic plaques were shown to contain 
bone marrow-derived α SMA expressing cells17. In line with this, human peripheral blood was shown to contain 
a population of smooth muscle progenitor cells18,19.
Much speculation therefore exists with respect to the precise roles of T cells in response to arterial injury 
which is complicated by the fact that researchers use diverse immunodeficiency models and different modes of 
arterial injury. Nevertheless, based on the available literature we hypothesized that the specific immune response 
to arterial injury depends on the method, and thereby severity, of arterial injury. Denudation wire-injury is 
considered a severe method to induce neointima formation. Here the endothelium is removed and the artery 
stretched due to the size of the guide-wire. The combination of denudation and arterial stretch results in robust 
neointima formation. The other model used in this study was the perivascular cuff method. Here the artery is 
sheathed with a polyethylene tube around the femoral artery. The tube is larger than the vessel so that the blood 
flow is not obstructed. The exact mechanism of neointima formation is currently unknown.
In this study we developed a humanized mouse model which would allow the investigation of: 1) the involve-
ment of human peripheral blood mononuclear cells (PBMCs) in the immune responses and subsequent neoin-
tima formation elicited by vascular injury, and 2) the contribution of human PBMC-derived α SMA expressing 
cells to neointima formation in 2 widely-used models for neointima formation in mice.
Results
Neointima formation after single vs. dual injury in BL/6 mice. Neointima formation may vary sig-
nificantly depending on the type of vascular injury20,21, including the contribution of circulation-derived α SMA 
expressing cells to neointima formation22. Since we wanted to study the differential effects of arterial injury (i.e., 
carotid wire versus femoral cuff injury) in NSG mice, we first had to validate the dual injury model and compare 
data with single injury. Both the carotid wire and femoral cuff injury model are widely used to study neointima 
formation, but to our knowledge these injuries have not been performed simultaneously in the same mouse. We 
carried out either single or dual injury in BL/6 mice which resulted in neointimal lesion formation 4 weeks after 
injury when compared to sham-operated mice (Fig. 1A–F). After single injury, the femoral cuff model appeared 
to induce slightly more neointima formation (expressed as % intimal expansion) when compared to carotid wire 
injury (23% vs. 28%, respectively, Fig. 1G). No significant differences in intimal expansion in femoral and carotid 
arteries were observed when comparing single injured and dual injured BL/6 mice (Fig. 1G). Similar to single 
injury, dual injury resulted in the development of an α SMA+ SMC-rich neointima (Fig. S2B,D). Thinning of the 
tunica media was observed in the femoral artery 4 weeks after cuff injury (Fig. S2D,E) yet the media of the carotid 
artery did not significantly differ after wire-injury (Fig. S2B,E). Masson’s trichrome staining identified collagen 
content in the media of the carotid artery after wire-injury (Fig. S2F). Yet, collagen deposition was not found in 
the neointima of either the carotid or femoral artery after injury (Fig. S2F,G). These data indicate that induction 
of dual injury does not influence the severity of neointima formation when compared to single injury.
Neointima formation after dual injury in non-reconstituted NSG mice. Next, we investigated 
the role of immunodeficiency on neointima formation as this has not been studied in NSG mice. Dual arterial 
injury was carried out in NSG mice and the damaged arteries analyzed 4 weeks later. Unlike our findings in BL/6 
mice, no neointima formation was observed in the wire-injured carotid arteries of NSG mice (P < 0.05 vs. BL/6 
mice, Fig. 1H). In contrast, the femoral artery cuff which was placed in the same mouse did induce neointima 
formation (P = 0.01 vs. NSG carotid artery) to an extent similar to what was found in immunocompetent BL/6 
mice (Fig. 1H). We therefore investigated the early response to dual vascular injury in NSG mice by examining 
the arteries of NSG mice 2 days after dual injury. Verhoeff-van Gieson staining (Fig. S3A), Masson’s trichrome 
staining (Fig. S4A–F) and immunofluorescent staining for α SMA (Fig. S3B,C) confirmed thinning of the fem-
oral artery media as a result of cuff placement. In addition, the total number of cells was also reduced after cuff 
placement (Fig. S3D). In contrast, the media area of the carotid artery slightly increased (Fig. S3C) yet the total 
number of cells in the media of both the carotid artery was severely reduced 2 days after injury (Fig. S3D). In the 
femoral artery, a reduction in the number of cells present in the adventitia was also observed but the number of 
cells remained unchanged in the adventitia of the injured carotid artery (Fig. S3D). The reduction in cell numbers 
is likely a result of apoptosis early after injury. Staining for vWF confirmed endothelial staining in sham-operated 
arteries (Fig. S3e.1,e.3). In contrast, only a few vWF+ endothelial cells were present in injured carotid and femoral 
arteries confirming endothelial denudation 2 days after injury (Fig. S3e.2,e.4). At 2 days after injury we found 
thrombus formation in the carotid arteries of all mice (n = 4) (Fig. S3a.2,a.3) but not in the femoral artery arteries 
(Fig. S3a.5,a.6) which may be due to the differences between the vascular injury methods. In addition, it may also 
reflect the heterogeneity of the vasculature. Despite the susceptibility for thrombus formation in carotid arteries 
early after injury, this clearly did not result in neointima formation 4 weeks after injury (Fig. 1H).
Generation of humanized NSG mice: engraftment of human PBMCs. To generate humanized 
NSG mice, we transferred 5 × 106 human PBMCs isolated from the peripheral blood of 5 healthy male donors 
to NSG mice. PBMCs from each donor were used to reconstitute NSG mice that received arterial injury (n = 2) 
as well as sham mice (n = 2). NSG mice engrafted with human PBMCs are known to eventually develop symp-
toms of graft-versus-host disease (GvHD) depending on the number of PBMCs transferred. However, minimal 
GvHD occurs at one month when transferring 5 × 106 PBMCs23. PBMCs were administered immediately after the 
dual arterial injury procedure was performed and mice sacrificed 28 days later. Reconstituted NSG mice showed 
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marked splenomegaly (Fig. 2A). Immunofluorescent labeling for h(uman) CD45 revealed massive splenic repop-
ulation with hCD45+ cells in engrafted NSG mice, whereas no hCD45+ were detected in non-reconstituted mice 
4 weeks after administration. These data were supported by flow cytometric analyses performed on peripheral 
blood and spleen 4 weeks after reconstitution (Fig. 2B,C). As expected, no hCD45+ cells were detected in NSG 
mice that had not received human PBMCs. Higher levels of engraftment were observed in the spleen (44%) as 
compared to that achieved in the blood (21%) at 4 weeks (P < 0.01, Fig. 2B–D). Vascular injury did not alter 
the amount of engrafted hCD45+ cells, as similar levels were found in both sham-operated and injured mice 
Figure 1. Neointima formation 4 weeks after dual vascular injury in BL/6 and NSG mice. Representative 
sections of carotid and femoral arteries from dual injured and sham-operated BL/6 mice stained with Verhoeff-
van Gieson (A–F). Neointima is indicated as tissue in between arrowheads. (A) Sham-operated control carotid 
artery, (B) Carotid artery after single wire-denudation injury, (C) Carotid artery after wire denudation in a dual 
injured mouse, (D) Sham-operated control femoral artery, (E) Single collar-injured femoral artery, and  
(F) Collar-injured femoral artery in a dual injured mouse. Abbreviations: a: adventitia; m: media; ni: neointima. 
(G) Intimal expansion in arteries of single (n = 5) and dual (n = 5) injured BL/6 mice. No significant difference 
in intimal expansion was detected when comparing single versus dual injured mice. (H) Intimal expansion 
measured in the arteries of dual injured BL/6 (n = 5) and NSG (n = 9) mice. No significant difference was 
found in the amount of neointima observed between the femoral arteries of BL/6 and NSG mice, whereas 
intimal expansion in the carotid artery of NSG mice was significantly reduced when compared with BL/6 mice 
(*P < 0.05). In NSG mice, femoral arteries displayed significant intimal expansion compared with carotid 
arteries (**P = 0.01). Data are expressed as mean ± SEM. Original magnification (A–F): 200x.
www.nature.com/scientificreports/
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(Fig. 2D). Almost all of the engrafted human cells in the blood and spleen were CD3+ (~99%) (data not shown). 
Within the population of hCD45+ cells the percentages of hCD4+ and hCD8+ cells were determined as depicted 
in Fig. 2E. The percentages of hCD4+ and hCD8+ in the blood and spleen were not significantly different in 
reconstituted NSG mice which had not received arterial injury compared to mice which had first received arterial 
injury (Fig. 2F,G). To determine GvHD in the PBMC-transferred NSG mice, we monitored for weight loss and 
performed haematological analyses at sacrifice. Although weight loss occurred shortly after arterial injury as a 
consequence of the surgical procedure, all mice had returned to their starting weight within a week and no differ-
ences were observed between PBMC-reconstituted and non-reconstituted mice (data not shown). A significantly 
higher number of white blood cells were detected in PBMC-reconstituted NSG mice (Fig. S5) which corresponds 
with the engraftment of human CD45+ cells (Fig. 2B). In NSG mice, red blood cell count, haemoglobin, haemat-
ocrit, and platelet counts were within the normal range and no differences were observed between reconstituted 
and non-reconstituted mice (Fig. S5B–E). These results confirm that the reconstituted NSG mice were not suffer-
ing from the detrimental effects of GvHD.
Plasma levels of human and mouse cytokines in humanized NSG mice. In order to analyze 
whether dual vascular injury modulates systemic human PBMC cytokine production in humanized mice which 
may influence neointima formation, plasma samples were analyzed for cytokine levels using an ultra-sensitive 
10-plex multiplex assay capable of detecting very low levels of human inflammatory cytokines. Plasma from 
both BL/6 mice and non-reconstituted (−PBMCs) NSG mice were used as controls. These control mice had no 
detectable levels of the human inflammatory cytokines analyzed (Fig. 3A–H). However, low levels of the human 
cytokines IL-1β (A), GM-CSF (B), IFNγ (C), IL-10 (D), IL-2 (G), and IL-5 (H) were measured in the plasma of 
mice reconstituted with human PBMCs (Fig. 3, white bars). Significantly elevated levels of IL-1β (P < 0.05, A), 
GM-CSF (P < 0.01, B, IFNγ (P < 0.01, C), and IL-10 (P < 0.05, D) were observed in PBMC-engrafted mice (com-
pared with non-reconstituted mice) 4 weeks after receiving dual arterial injury (Fig. 3, black bars). Although not 
significant, increased plasma levels of human IL-2 (G), IL-5 (H), IL-6 (E) and TNFα (F) were also observed in 
reconstituted mice which had received dual arterial injury compared to uninjured reconstituted mice (Fig. 3). 
Inflammatory cytokines of mouse origin (IL-1β , IL-5 and IL-6) were not detected in the plasma of (non-) recon-
stituted NSG mice with or without arterial injury (data not shown).
Figure 2. Engraftment of human PBMCs into NSG mice 4 weeks after reconstitution. NSG mice were 
reconstituted with 5 × 106 human PBMCs by retro-orbital injection. Engrafted spleens showed marked 
splenomegaly and were repopulated with hCD45+ cells as revealed by immunofluorescent labeling 
(A). Engraftment of peripheral blood (B) and spleen (C) was evaluated by flowcytometry 4 weeks after 
reconstitution. Values of individual mice and median engraftment levels are shown (***P < 0.001). No 
differences in the engraftment of human CD45+ cells was observed in NSG mice which had first received 
arterial injury compared to sham-operated mice. Engraftment in spleen was significantly higher than in 
peripheral blood (**P < 0.01) (D). Representative dot plots of human PBMC-engrafted spleens are shown in 
panel (E). Human CD4+ and CD8+ cells were gated on live hCD45+ cells (E) and percentages given represent 
values of hCD4+ and hCD8+ cells within the hCD45+ population in peripheral blood (F) or spleen (G). The 
n-value reflects the number of mice included. Data are expressed as mean ± SEM.
www.nature.com/scientificreports/
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Neointima formation in dual injured PBMC-engrafted and non-reconstituted NSG mice. We 
next examined the effect of human PBMC reconstitution in NSG mice on neointima formation after dual arterial 
injury. Significant neointima formation was found in the carotid artery of reconstituted NSG mice four weeks 
after arterial injury yet no neointimal lesions were observed in carotid arteries of NSG mice without human cell 
reconstitution (P < 0.01 vs. non-reconstituted NSG, Fig. 4A,C,E,G). In contrast, neointima formation was signif-
icantly reduced in the femoral arteries of reconstituted NSG mice when compared with non-reconstituted mice 
(P < 0.05, Fig. 3B,D,F,G). Similar results were obtained when expressing data as Intima/Media ratio (Fig. 4H).
Smooth muscle cell phenotypic modulation after arterial injury. In order to determine the SMC 
phenotype of neointimal cells in injured carotid and femoral arteries we performed immunofluorescent double 
labeling for α SMA/calponin and α SMA/SM22α . Non-injured carotid and femoral arteries were used as positive 
controls since differentiated medial SMCs within these arteries are known to express α SMA, SM22α and calponin 
(Fig. 5A–D, left panels). Medial SMCs in injured arteries also expressed all three SMC markers (Fig. 5A–D, right 
panels). In contrast, neointimal lesions in both the carotid and femoral arteries were characterized by low α SMA 
expression accompanied with reduced expression of SM22α and calponin supporting a de-differentiated prolifer-
ative SMC phenotype. Production of excessive connective tissue as a result of SMC phenotypic modulation from 
the contractile-type to the de-differentiated synthetic-type is proposed to play a major role in the response to 
vascular injury. Trichrome staining (Martius Scarlet Blue [MSB] revealed minimal collagen content in the media 
of sham-operated carotid (Fig. S4A,G) and femoral arteries (Fig. S4D,J). In contrast, MSB staining revealed exten-
sive collagen deposition in the neointima of carotid arteries (Fig. S4I) and in the media of femoral arteries (Fig. 
S4L) of reconstituted mice 4 weeks after injury. In immunodeficient mice, collagen deposition in the neointima 
was minimal after femoral artery cuff injury (Fig. S4K) and was absent in the media of the carotid artery after 
wire-injury (Fig. S4H). Hence, SMC phenotypic modulation was independent of the immune status of the mice. 
However, in contrast to immunocompromised (no PBMCs) mice, collagen deposition found in the neointima 
and media of injured arteries appeared to be more extensive in the arteries of reconstituted mice.
Human leukocyte infiltration in dual injured PBMC–engrafted NSG mice. In order to deter-
mine if the differences in neointima formation in injured femoral and carotid arteries in PBMC-reconstituted 
and non-reconstituted NSG mice were associated with human leukocyte infiltration, double immunofluo-
rescent labeling was performed on arterial sections using human-specific antibodies against pan-leukocytes 
(hCD45), T cell subsets (hCD4 and hCD8) and macrophages (hCD68) combined with α SMA. The species 
specificity of the human-specific antibodies was confirmed by staining spleen sections of PBMC-reconstituted 
and non-reconstituted NSG mice as well as human appendix (positive control) with the appropriate antibodies 
Figure 3. Plasma human cytokine levels in NSG mice reconstituted with (+) and without (−) 5 × 106 
human PBMCs, and with and without (sham) arterial injury. Plasma concentrations of human IL-1β 
(A), GM-CSF (B), IFNγ (C), IL-10 (D), IL-6 (E), TNFα (F), IL-2 (G) and IL-5 (H) were analyzed using an 
ultrasensitive cytokine bead array 4 weeks after PBMC reconstitution and arterial injury. Significant differences 
between injured and sham-operated reconstituted mice were found for IL-1β , GM-CSF, IFNγ and IL-10. The 
n-value reflects the number of mice included. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01.  
(nd =  not detectable; ns =  not significant).
www.nature.com/scientificreports/
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using immunohistochemistry (Fig. S6) and immunofluorescence (Fig. S7). Staining of injured carotid artery sec-
tions revealed the presence of human PBMC-derived hCD45+ leukocytes in large numbers in the adventitia 
but also within the neointima 4 weeks after injury (Fig. 6A). The majority of these hCD45+ cells appeared to 
be hCD8+ (Fig. 6C), whereas only few hCD4+ cells were observed within the neontima (Fig. 6B). Moreover, no 
human-derived CD68+ macrophages were found within the neointima, media or adventitia of the injured carotid 
artery (Fig. 6D). In PBMC-reconstituted mice virtually no neointimal lesions were present within the femoral 
arteries of the same dual injured mice. In the adventitia of these arteries hCD45+ were present (Fig. 6E) which 
were found to be primarily hCD8+ cells (Fig. 6G). No hCD4+ or hCD68+ cells were found (Fig. 6F,H).
No human-PBMC derived SMCs and ECs in dual injured PBMC-engrafted NSG mice. Neointimal 
SMCs expressing α SMA may be in part derived from circulating presumed myeloid, progenitor cells. To analyze 
whether in our humanized mouse model PBMC-derived α SMA expressing neointimal cells were present, double 
labeling was performed for hCD45 (as well as hCD4, hCD8 and hCD68) and α SMA. Although hCD45+ cells were 
present in the α SMA+ neointima, clearly no CD45+α SMA+ double positive cells were detected (Fig. 6A). The 
same was true for the other markers included (hCD4, hCD8 and hCD68, Fig. 6B–D). In addition, high resolution 
confocal microscopy revealed no co-expression of hCD45 or hCD8 with SMA+ neointimal SMCs (Fig. 6I,J). 
These data suggest that the α SMA+ SMCs in carotid neointimal lesions in humanized NSG mice are not derived 
from human PBMCs.
In Fig. S3 we showed endothelial denudation in both carotid and femoral arteries early after injury. This 
observation raised the question whether re-endothelialization is mediated (in part) by endothelial progenitor 
cells which are known to reside within the PBMC fraction. To address this question, species-specific immuno-
fluorescence was performed using antibodies directed against hCD31 and mCD31. The specificity of the hCD31 
Figure 4. Neointima formation 4 weeks after dual vascular injury in NSG mice reconstituted with or 
without human PBMCs. Representative sections of carotid and femoral arteries from dual injured and sham-
operated mice stained with Verhoeff-van Gieson. (A) Sham- operated control carotid artery, (B) Sham-operated 
control femoral artery, (C) Carotid artery after wire injury in a non-reconstituted NSG mouse, (D) Femoral 
artery after cuff injury in a non-reconstituted NSG mouse, (E) Carotid artery after wire injury in a human 
PBMC-reconstituted NSG mouse, (F) Femoral artery after cuff injury in a human PBMC-reconstituted NSG 
mouse. Squares indicate areas shown at higher-power magnification of the respective cross-sections (C.1, D.1, 
E.1, F.1). Neointima is indicated as tissue in between arrowheads. Neointima formation in the carotid and 
femoral arteries of dual injured NSG mice reconstituted with (n = 6) and without (n = 9) human PBMCs was 
expressed as % intimal expansion (G) and intima/media ratio (H). *P < 0.05, **P < 0.01. Data are expressed 
as mean ± SEM. Abbreviations: m: media; ni: neointima; PBMCs: human peripheral blood mononuclear cells. 
Original magnification (A–F): 200x.
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antibody was confirmed on human venous tissue (Fig. S7B). In sham-operated carotid and femoral arteries, both 
in non-reconstituted (Fig. 7A,I) and PBMC-reconstituted (Fig. 7C,K) NSG mice the endothelium was of mouse 
origin. Also 4 weeks after injury, both in non-reconstituted (Fig. 7B,J) and PBMC-reconstituted (Fig. 7D,L) mice 
the endothelium was of mouse origin. Human PBMC-derived ECs were never detected in carotid (Fig. 7E–H) 
and femoral (Fig. 7M–P) arteries. Similar to neointimal SMCs, these data indicate that ECs in injured arteries in 
humanized NSG mice are not derived from human PBMCs.
Neointima formation in the femoral artery after wire-injury. To determine whether the type of 
artery or the method of inducing injury (wire vs cuff) is important we also performed wire-injury in the femoral 
artery of NSG mice with or without PBMC reconstitution. Four weeks after surgery and reconstitution the level of 
chimerism in the peripheral blood was about 22% (Fig. 8A) consistent with our other studies (Fig. 2B). In contrast 
to the carotid artery, femoral artery wire injury resulted in neointima formation already without reconstitution. 
Furthermore, reconstitution with hPBMCs did not attenuate neointima formation in wire-injured femoral arter-
ies (Fig. 8B,C). Hence, neointima formation in the femoral artery of immunocompromised mice is not dependent 
on the type of vascular injury since both the cuff and wire injury resulted in around 20% neointimal expansion.
Discussion
The mechanisms underlying restenosis development following PCI remain unclear. As a consequence addi-
tional experimental models are needed to investigate the interaction between the (human) immune system and 
the vascular wall in neointima formation. In the current study we developed a humanized mouse model based 
on the immunodeficient NSG mouse strain. NSG mice lack functional T cells, B cells, and NK cells. Moreover 
NSG mice have functional defects in macrophages, and dendritic cells and have no hemolytic complement24,25. 
Reconstitution of NSG mice enabled us to investigate the involvement of human PBMCs in the immune responses 
and subsequent neointima formation elicited by vascular injury, and, secondly, to determine the contribution of 
human PBMC-derived α SMA expressing cells to neointima formation. The severity of neointima formation and 
the contribution of circulating cells to neointimal lesions varies depending on the type of vascular injury20–22,26. 
We therefore applied two commonly used experimental methods of vascular injury, i.e. carotid artery wire injury 
and femoral artery cuff injury, together in the same mouse to study the effect of human PBMC reconstitution on 
neointima formation. Wire injury results in endothelial denudation and is known to disrupt the internal elastic 
lamina and the media whereas placement of a polyethylene cuff loosely over the femoral artery stimulates slow 
sloughing of the endothelium within 1–2 days after placement27. We hypothesized that differences in the severity 
of injury and the exposed denuded vasculature would influence endothelial regeneration, homing of inflamma-
tory and progenitor cells, and the proliferation of medial SMCs.
Figure 5. Neointimal cells in the injured carotid (PBMC-engrafted NSG mice) and femoral (non-PBMC-
engrafted NSG mice) artery express αSMA, calponin and SM22α. Sham-operated (non-injured) and 
wire-injured carotid arteries stained for α SMA/calponin (A) and α SMA/SM22α (B). Sham-operated and 
cuff-injured femoral arteries stained for α SMA/calponin (C) and α SMA/SM22α (D). As negative control, 
cuff-injured femoral arteries were incubated according the protocol but with omitting primary antibody 
incubation (E). Insets and single stainings show high power magnifications of the boxed regions. Acquired 
photomicrographs were converted into pseudocolored images and merged using ImageJ 1.47v (http://imagej.
nih.gov/ij). Abbreviations: a: adeventitia; m: media; ni: neointima.
www.nature.com/scientificreports/
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Dual injury in immunocompetent BL/6 mice resulted in neointima formation in both the carotid and femoral 
arteries. However, in non-reconstituted NSG mice significant neointima formation was observed only in the 
femoral artery 4 weeks after cuff placement. This observation is in line with previous studies in immunodeficient 
Rag1−/− mice also showing intimal hyperplasia after femoral artery injury7,8. In contrast, we surprisingly found no 
neointima formation in the carotid artery of the same non-reconstituted NSG mice. We had expected substantial 
neointima formation after wire-induced injury in the carotid artery since this model is thought to be more severe 
when compared to the perivascular cuff model of the femoral artery28. From these results we concluded that 
immunodeficiency protects against neointima formation which is dependent on the type of injury. To our knowl-
edge, this is the first study that describes the differential (both protective and stimulatory) effects of immunodefi-
ciency on simultaneous carotid wire-injury and femoral artery cuff-injury induced neointima formation in mice.
We next examined the effect of reconstitution on neointima formation after dual arterial injury in NSG mice. 
High levels of human lymphocyte engraftment with primarily CD3+ T cells were observed in peripheral blood 
and spleen 4 weeks after reconstitution. In contrast to what we observed in NSG mice without reconstitution, we 
found that the femoral artery in humanized mice developed no neointima 4 weeks after arterial injury whereas 
the carotid artery developed severe neointimal lesions. These results indicate that human cell reconstitution, 
which was predominantly composed of T cells, protects against neointima formation in the femoral artery after 
cuff injury but not after wire-induced injury, and promotes neointima formation in the carotid artery after 
wire-induced injury.
Since femoral and carotid arteries are diametrically different (i.e. femoral arteries are approximately 3 
times smaller in diameter), the severity of vascular injury induced by the guide wire is most likely different (i.e. 
increased damage in femoral artery), and consequently the remodeling response. Carotid arteries have 3 layers 
of elastin and 2 layers of SMCs, whereas the femoral artery has 2 layers of elastin and only one layer of SMCs. In 
Figure 6. Presence of human PBMC-derived cells within injured carotid (A–D) and femoral (E–H) arteries in 
NSG mice 4 weeks after reconstitution with 5 × 106 human PBMCs. Sections were immunofluorescently stained 
with α SMA (in red) and specific antibodies (in green) recognizing human CD45 (A,E), human CD4 (B,F), 
human CD8 (C,G) and human CD68 (D,H). Representative images of arterial staining from 3 different mice per 
group. Specificity controls for the antibodies used are shown in Figs S6 and S7A. Nuclei were stained with DAPI 
(in blue). Dotted line indicates the internal elastic lamina. Arrows indicate positively stained human leukocytes. 
Original magnification: 400x. Confocal microscopy ortho images hCD45/α SMA (I) or hCD8/α SMA (J) on 
wire-injured femoral arteries. Abbreviations: a: adventitia; m: media; ni: neointima.
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addition to the amount of media (SMCs), vessel elasticity, hemodynamic responses, the basement membrane and 
other factors such as residual endothelium play important roles in driving the response to arterial injury. Based 
on our results we could not discriminate whether the type of artery or the method of inducing injury is the most 
important factor in driving neointima formation in immunodeficient NSG mice. We therefore also performed 
femoral artery wire injury in NSG mice with or without PBMC reconstitution. Wire-injured femoral arteries 
developed neointimal lesions to a similar extent as that observed in femoral cuff injured arteries (approximately 
20% intimal expansion) in NSG mice without reconstitution. These results suggest that neointima formation 
in the femoral artery is not dependent on the type of vascular injury in immunocompromised mice. Moreover, 
because of the severity of wire-injury (denudation and stretching) in the femoral artery we speculate that occlu-
sion may not be able exceed more than 20% intimal expansion which is likely attributed to an intrinsic property 
of the femoral artery itself. Besides, the carotid artery is composed of a larger SMC-rich media compared to the 
femoral artery which may explain why the carotid artery has more neointima formation compared to the femo-
ral artery after injury. In reconstituted NSG mice, wire-injury of the femoral artery did not attenuate neointima 
formation (20% intimal expansion) compared to femoral cuff arteries with only 4% intimal expansion. These 
results are in line with substantial neointima formation observed in the carotid artery after wire injury in recon-
stituted NSG mice. Likely the immediate and complete removal of the endothelial layer in the femoral artery after 
wire-injury promotes the recruitment of the hPBMCs which were systemically administered to the mice immedi-
ately after the surgical procedure. These results suggest that direct recruitment of hPBMCs to the injured arterial 
wall has detrimental effects (i.e. enhancing or loss of protective effects) which drive neointima formation in the 
denuded arteries. In contrast, EC removal is slower by the perivascular cuff which likely results in the differential 
Figure 7. No re-endothelialization of carotid (A–H) and femoral (I–P) arteries with human PBMC-derived 
CD31+ endothelial cells in NSG mice 4 weeks after reconstitution with 5 × 106 human PBMCs. Sections from 
sham-operated and injured carotid and femoral arteries obtained from both human PBMC reconstituted 
(+ PBMCs) and non-reconstituted (− PBMCs) NSG mice were included in this analysis. Sections were 
immunofluorescently stained with anti-human CD31 (hCD31) and anti-mouse CD31 (mCD31) species-specific 
antibodies. Representative images of arterial staining from 3 different mice per group. Specificity controls for 
the hCD31 antibody is shown in Fig. S6B. Nuclei were stained with DAPI (blue). Arrowheads indicate positively 
stained CD31+ endothelial cells. Abbreviations: l: lumen; m: media; ni: neointima; PBMCs: human peripheral 
blood mononuclear cells. Original magnification: 400x.
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effects of hPBMCs on neointima formation seen in our study. Together, these results importantly highlight the 
complexity of neointimal lesion formation and the role of T cells in this process and suggest that the immune 
system may differentially respond to arterial injury depending on the method of injury, which may also be influ-
enced by the intrinsic properties of the arteries themselves.
After arterial injury apoptosis may play an important role on limiting vascular SMC proliferation and corre-
sponding neointima formation. However, excessive apoptosis can lead to necrosis and inflammation. In a rat arte-
rial injury model, 2 waves of apoptosis were identified, early from 30 min until 6 hours after injury initiation, and 
late apoptosis around 2 weeks after arterial injury29. Early apoptosis can lead to inflammation which is thought to 
contribute to the remodelling process. We found severely reduced numbers of SMCs in the media of the carotid 
and femoral arteries at 2 days after injury. In addition, adventitial cells were also reduced. This reduction in the 
amount of cells is likely due to apoptosis.
In our study, no human PBMC-derived neointimal SMCs were detected, indicating that the α SMA+ neoin-
timal SMCs were of mouse origin. This is remarkable as it was previously shown that endovascular wire-injury 
in mice results in neointimal lesions containing significant numbers (~27%) of bone marrow-derived α SMA+ 
cells22. A possible explanation might be that engrafted PBMCs in NSG mice are primarily T cells whereas it has 
been shown that circulating smooth muscle progenitor cells probably reside within the myeloid population18,19. 
Moreover, no human PBMC-derived ECs were detected in the injured femoral and carotid arteries. These data 
are in line with a report by Hagensen and colleagues in which it was shown that circulating endothelial progenitor 
cells do not contribute to endothelial regeneration after murine arterial injury30.
Immune cells play a crucial role in the formation of neointimal lesions by inducing the production of 
cytokines and chemokines that may affect EC and SMC survival, proliferation, migration and activation. As 
expected, we were unable to detect cytokines of mouse origin in any of the experimental NSG groups since these 
mice have impaired cytokine signaling. In contrast, 4 weeks after reconstitution non-injured NSG mice had basal 
levels of several human cytokines, yet mice that had received dual arterial injury had significantly higher levels of 
IL-1β , GM-CSF, IFNγ and IL-10. These data indicate that vascular injury triggered a functional cytokine release 
response in humanized mice. The contribution of these cytokines to neointima formation is not fully elucidated 
but manipulation of cytokines is a potential therapeutic option for the prevention or treatment of restenosis. 
This is also supported by clinical data obtained with sirolimus-eluting stents which significantly reduced in stent 
restenosis31. Cytokines such as IFNγ are thought to increase pro-inflammatory activity following coronary inter-
vention and might therefore be related to the long-term complications after intervention32,33. Likewise, GM-CSF 
has been implicated in atherogenesis34 and has been shown to have both pro- and anti-atherogenic properties35 
whereas GM-CSF deficiency in mice was shown to delay neointima formation after arterial injury36. Similarly, 
IL-10 is an anti-inflammatory cytokine with anti-atherogenic potential which has been shown to inhibit neoin-
tima formation after femoral artery injury in hypercholesterolemic mice37–39 and rabbits40. This IL-10-induced 
attenuation of neointima formation was attributed to its powerful inhibitory effects on the activation and growth 
of SMCs. Based on these published data we suspect that the increased cytokine levels, as detected in engrafted 
NSG mice after injury, may have had a direct effect on SMC behaviour and resulting neointima formation. 
However, a number of species-specific factors in mice are not cross-reactive with human cells and vice-versa. 
Therefore, the pro- and anti-inflammatory factors of human origin measured in the plasma of our mice may have 
Figure 8. Neointima formation 4 weeks after femoral artery wire injury in NSG mice reconstituted with 
or without human PBMCs. (A) NSG mice reconstituted with 5 × 106 hPBMCs and engraftment of peripheral 
blood was evaluated by flow cytometry 4 weeks after reconstitution. (B) Neointima formation in the wire 
injured femoral arteries of NSG mice reconstituted with (n = 7) and without (n = 8) hPBMCs was expressed as 
% intimal expansion and (C) intima/media ratio ***P < 0.001. Data are expressed as mean ± SEM.
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had no influence on the neointima formation observed in this study. Human GM-CSF and IFNγ are known to 
be only biologically active on human cells41,42 and therefore probably have little influence on neointimal lesion 
formation after dual arterial injury in mice. However, human IL-10 does have cross-species activity and is known 
to be active on mouse cells43,44. We therefore presume that the IL-10 measured in our mice would have had an 
influence on the neointima formation observed in the current study and may be protecting against neointima 
formation after femoral artery cuff injury as observed in previous studies36. However, further studies are required 
to confirm if this is indeed the case.
Animal models of restenosis provide a tool for investigating the pathophysiological mechanisms as well as 
translational approaches to vascular interventions. Several murine experimental models exist, carotid and fem-
oral artery wire injury are widely accepted as the most appropriate techniques in studies of post-angioplasty 
restenosis because it closely resembles the angioplasty procedure that injures both the endothelium and vessel 
wall driving neointima formation. The perivascular cuff method does not exactly mimic what happens in humans 
undergoing percutaneous coronary interventions but is widely used in the literature as a method to understand 
neointima formation. Moreover, it may be adopted as a model system for testing the perivascular delivery of 
therapeutic compounds in order to inhibit restenosis. Many conclusions are drawn from mouse models of arterial 
injury which have contributed to our general understanding of the mechanisms promoting neointima formation. 
However, whether these translate directly to the human situation is unclear. Our findings emphasize the impor-
tance of using the most accurate experimental model when investigating mechanisms of neointima formation 
and preclinical intervention studies.
Most studies to date described the effects of the normal immune system on neointima formation although it 
is known that immune cell function might be impaired in subjects at increased cardiovascular risk. A strength 
of the humanized mouse model described here is that this model can be adopted to understand the immune 
responses of vascular injury in populations which have a high risk of developing restenosis, e.g. diabetes45,46. 
Recent data indicate that immune and progenitor cells from type 2 diabetic subjects are naturally skewed towards 
pro-inflammatory subsets that likely promote chronic inflammation46. Understanding the unique aspects of T 
cells from diabetic patients as well as understanding their influence on neointima formation is essential in order 
to develop pharmaceutical agents to target restenosis.
In conclusion, we have developed a humanized NSG dual vascular injury model which allows us to study 
the contribution of the T cell system on neointima formation. We propose that the immune system differen-
tially responds to arterial injury depending on the severity of injury which may also be influenced by vascular 
heterogeneity.
Methods
C57BL/6 and NOD.Cg-PrkdcscidIL2rgtm1Wjl mice. Male 10-week-old C57BL/6 (BL/6) mice were pur-
chased from Harlan (Horst, The Netherlands), housed under standard housing conditions and given free access to 
food and water. Male 10-week-old NOD.Cg-PrkdcscidIL2rgtm1Wjl (NSG, Jackson Laboratory, Bar Harbor, ME) were 
housed in a specific pathogen-free facility in micro-isolator cages and given free access to autoclaved food and 
water. All experimental procedures were performed according to European Commission guidelines and Dutch 
laws and were approved by the animal ethics committee of the University of Groningen.
Mouse carotid wire injury and femoral cuff injury models. In this study two different types of vas-
cular injury were induced in the same BL/6 or NSG mouse. Both left common carotid artery (wire-injury) and 
right femoral artery (femoral cuff injury) of each mouse were injured to induce neointima formation. In contrast 
to carotid wire-injury, in the femoral cuff model the endothelial cells are not directly manipulated or removed. 
Mice were anesthetized with 2% isoflurane/O2 followed by carotid or femoral artery endothelial denudation and/
or femoral artery cuffing. Briefly, the left carotid artery and its muscular branch or the left femoral artery was 
exposed, and a 0.014′ (0.36 mm) diameter angioplasty guide-wire (Cook Medical Europe Ltd., Limerick, Ireland) 
introduced into the arterial lumen and pulled back three times. Removal of the endothelium was confirmed by 
in vivo Evan’s blue staining in injured arteries compared with uninjured arteries (data not shown). For induction 
of cuff femoral artery injury, a non-constrictive polyethylene cuff (0.4 mm inner diameter, 0.8 mm outer diam-
eter, length 2 mm, Portex, Kent, UK) was loosely placed around the right femoral artery. Contra-lateral carotid 
and femoral arteries as well as sham-operated mice were used as controls. Mice were euthanized at two days or 
four weeks after injury by deep anesthesia (5% isoflurane/O2) and exsanguination. Spleen and peripheral blood 
(collected in EDTA vacutainers (BD Biosciences, Franklin Lakes, NJ, USA)) were obtained, plasma was isolated 
and stored at − 80 °C until use. After subsequent in situ cardiac perfusion with zinc fixative47, arteries were col-
lected for histology. Haematological analyses were performed using the Poch-100i haematology analyser (Sysmex 
Nederland, Etten-Leur, the Netherlands) according to the manufacturer’s instructions.
Isolation of human PBMCs for engraftment. Human PBMCs were obtained from five healthy male 
volunteers (average age 26 years) under signed informed consent in accordance with the 1964 Declaration of 
Helsinki (revised October 2008, Seoul) and approval from the Medical Ethical Committee of the University 
Medical Center Groningen. Whole blood samples were obtained by venipuncture and collected in EDTA 
Vacutainers. PBMCs were purified by Ficoll-Paque (GE Healthcare Europe GmbH, Diegem, Belgium) density 
centrifugation and resuspended in Hank’s buffer solution for retro-orbital injection into NSG mice at a cell dose 
of 5 × 106 cells (in 200 μ l). NSG mice were reconstituted with the human PBMCs immediately after the dual 
injury surgical procedure. The following experimental groups were included: (i) untreated NSG mice, (ii) NSG 
mice given 5 × 106 PBMCs 4 weeks prior to analyses, (iii) NSG mice given 5 × 106 PBMCs and dual arterial 
injury 4 weeks prior to analyses, and (iv) NSG mice which received only dual arterial injury 4 weeks prior to 
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analyses. PBMCs of each donor were used to reconstitute 4 NSG mice: n = 2 with and n = 2 without (sham) arte-
rial injury. Four weeks after injection, human PBMC engraftment was evaluated in spleen and peripheral blood 
by flowcytometry.
Antibodies and flow cytometry. Flowcytometry analysis of human PBMC cell populations in engrafted 
NSG mice 4 weeks after reconstitution, anti-h(uman)CD3 (clone UCHT1), hCD4 (clone RPA-T4), hCD8 (clone 
HIT8a), hCD14 (clone Mϕ P9), hCD16 (clone 3G8), hCD45 (clone H130), and anti-m(ouse)CD45 (clone 30-F11) 
fluorochrome-conjugated mAbs and appropriate isotype controls (all from Biolegend, San Diego, CA, USA) were 
used. Antibodies were conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin chlo-
rophyll (PerCP), allophycocyanin (APC), phycoerythrin-Cyanin 5 (PE-Cy5), phycoerythrin-Cyanin 7 (PE-Cy7) 
or Alexafluor700. Single-cell suspensions of mouse spleen (depleted of erythrocytes) and peripheral whole 
blood were incubated with anti-CD16/32 (BD Biosciences) for 5 min at 4 °C to block non-specific Fc binding. 
Antibodies at the appropriate dilutions were incubated with splenocytes or 200 μ l whole blood for 30 min at 4 °C. 
Following red blood cell lysis, blood samples and labeled splenocytes cells were fixed in 1% paraformaldehyde in 
phosphate-buffered saline. At least 20,000 events were acquired with an LSR II instrument and analyzed using 
FACS DIVA software (BD Biosciences).
Measurement of human cytokine levels in NSG mice. The Cytokine Human Ultrasensitive 10-Plex 
Panel for the Luminex® platform (Invitrogen Corporation, Carlsbad, CA, USA) was carried out to determine the 
PBMC-engrafted NSG mouse plasma concentrations of human IFNγ , IL-6, IL-4, IL-1β , IL-10, IL-8, GM-CSF, 
IL-2, IL-5 and TNFα .
Quantification of neointima formation and medial area. After sacrifice, isolated zinc-fixed carotid 
and femoral arteries were dehydrated and embedded in paraffin. Serial cross-sections (3 μ m) were cut and histo-
morphometric analysis was performed at 20 cross-section levels (with 66 μ m intervals) (Fig. S1).
Sections at each level were stained with Verhoeff-van Gieson or Masson’s trichrome for collagen content and 
slide images captured using a Hamamatsu Nanozoomer 2.0HT (Hamamatsu Photonics, Hamamatsu, Japan). 
Morphometric analysis was performed using Aperio Imagescope software (Aperio Technologies inc, CA, USA). 
Percentage intimal expansion throughout the arterial segment was calculated with the following formula: % inti-
mal expansion = ((AI − AL)/AI)) × 100; where AI is the area within the internal elastic lamina and AL is the luminal 
area. The intima/media (I/M) ratio was calculated with the following formula: I/M ratio = (AI − AL)/(AM − AI); 
where AM is the area within the external elastic lamina. The media and adventitial areas were also quantified. To 
determine loss of cells after vascular injury, the total number of cells in media and adventitia were quantified. 
Serial sections, as depicted in Fig. S1, were quantified to determine the mean % intimal expansion per artery. The 
number of sections analyzed was an average of 12 (range 9–17) per injured artery and an average of 4 sections 
(range 3–5) per control artery.
Detection of human PBMC-derived cells using immunofluorescence. Zinc-fixed paraffin-embedded 
sections were deparaffinized in xylol, rehydrated in graded ethanol series and demi-water, and then stained using 
the following antibodies: anti-h-α SMA (clone 1A4), hCD4 (clone 4B12), hCD8 (clone C8/144B), hCD68 (clone 
KP-1), hCD45 (clone 2B11 + clone PD7/26), vWF (clone F8/86), hCD31 (clone JC70A) (all from DAKO, Glostrup, 
Denmark) and anti-mouse CD31 (clone MEC 13.3; BD Pharmingen). Sections were first blocked with 3% BSA 
and subsequently incubated for 1 hour with primary antibodies. Binding of primary antibodies was detected by 
incubating with the appropriate fluorescently-labeled secondary antibodies: goat anti-mouse IgG1-Alexafluor488 
and goat anti-mouse-Alexafluor555 (both from Invitrogen) and goat anti-rabbit IgG-Cy3 (Invitrogen) or rab-
bit anti-rat biotin (DAKO). Biotinylated antibody complexes were detected with streptavidin-Alexafluor555 
(Invitrogen). Sections were mounted in Aqua/polymount (Polysciences Inc., Warrington, PA, USA) containing 
DAPI (1.5 μ g/ml; Invitrogen). Fluorescence microscopy was performed using a Leica DMLB microscope (Leica 
Microsystems, Rijswijk, The Netherlands) equipped with a Leica DC300F camera and Leica QWin 2.8 software. 
To confirm antibody specificity, immunohistochemistry was performed on zinc-fixed (NSG spleen with or 
without human PBMCs) or formalin-fixed (human appendix) paraffin sections. Sections were deparaffinized in 
xylol, rehydrated in graded ethanol series and demi water, and subsequently stained using immunohistochem-
istry in a Ventana Benchmark Ultra automated IHC/ISH slide staining system (Ventana Medical Systems, Inc.). 
For confocal microscopy, sections were deparaffinized in xylol, rehydrated in graded ethanol series and demi 
water, followed by heat-induced epitope retrieval (HIER) in 10 mM Sodium Citrate Buffer (pH 6.0) for 20 min 
in a microwave (300 W). The Mouse on Mouse (M.O.M.) Basic Kit (Vector® Laboratories) was used, followed by 
incubation with primary antibodies (CD45/α SMA and CD8/α SMA) and goat anti-mouse IgG1-Alexafluor488 
and goat anti-mouse-Alexafluor555 secondary antibodies as described above. Nuclei were stained with DAPI (Life 
Technologies) and mounted in Fluorescence Mounting Medium (DAKO). Confocal microscopy was performed 
using an inverted microscope (Zeiss LSM 780 NLO; Axio Observer Z1).
Phenotypic characterization of SMCs in sham-operated and injured carotid and femoral arteries. 
To analyse whether neointimal α SMA + cells are SMCs, immunofluorescent double labeling was performed. 
Heat-induced epitope retrieval (HIER) was performed in 10 mM Sodium Citrate Buffer (pH 6.0) for 20 min 
in a microwave (300 W). Sections were blocked with 3% BSA and subsequently incubated for 1 hour with pri-
mary antibodies diluted in PBS/1% BSA. The following primary antibodies were used: α SMA (mIgG2a, clone 
1A4), SM22α (rabbit polyclonal ab14106, Abcam), and calponin (rabbit polyclonal ab46794, Abcam). Binding 
of primary antibodies was detected by incubating with fluorescently-labeled secondary antibodies. For α SMA, 
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goat-anti-mouse IgG2a-Alexafluor555 (Invitrogen) or goat-anti-mouse IgG2a-biotin (SouthernBiotech) were 
used. Biotin was detected with streptavidin-AlexaFluor488 conjugate (Molecular Probes). For SM22α and cal-
ponin, goat anti-rabbit IgG-FITC (DAKO) or goat anti-rabbit Cy3 (Zymed Laboratories) were used. Nuclei were 
stained with DAPI (BioLegend) and mounted in Fluorescence Mounting Medium (DAKO). Images were acquired 
using TissueFAXS acquisition software (TissueGostics) on a Zeiss Axio Observer Z1 inverted microscope.
Statistical analysis. Statistical evaluations were performed with Graphpad Prism software (version 5; La 
Jolla, CA, USA). Data are presented as mean ± SEM. Differences in the means of parametric data were com-
pared by one-way ANOVA with Bonferroni post-tests. Medians of non-parametric data were compared using the 
Mann–Whitney U-test.
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